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The type III iodothyronine deiodinase (ID-III) catalyzes the inner ring deiodination and, thus, the inactivation of the thyroid hormones T4 and 
Tj. ID-III activity in rat brain, rat placenta nd embryonic hicken liver is inhibited by the affinity label N-bromoacetyl-T, (BrAcT,) with an affinity 
similar to that of T,. Reaction of rat brain and placenta microsomes with BrAc[‘*‘I]T, resulted in the extensive labeling of a 32 kDa protein (~32). 
However, p32 was also prominently labeled in fetal rat liver microsomes which have no ID-III activity. Labeling of p32 was not influenced by 
100 PM substrate analogs or inhibitors of ID-III, some of which completely inhibit ID-III activity at 1 PM. BrAc[‘*‘I]T~ labeling of embryonic 
chicken liver microsomes did not reveal p32 or another protein possibly related to ID-III. In contrast to previous suggestions, it is unlikely that 
p32 represents ID-III or a subunit thereof. 
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1. INTRODUCTION 
The thyroid predominantly secretes the inactive pro- 
hormone thyroxine (TJ. Therefore, extrathyroidal 
outer ring deiodination to bioactive 3,3’,5triiodothy- 
ronine (TJ is an essential step in the exertion of thyroid 
hormone action. Alternatively, T4 is converted by inner 
ring deiodination to the inactive metabolite 3,3’,5’-triio- 
dothyronine (reverse T,, rTJ. Inner ring deiodination 
also inactivates T3 by converting it to 3,3’-diiodothyron- 
ine (3,3’-T,) [1,2]. 
in the microsomal fractions of brain [9], placenta [lo], 
skin [ll] and fetal intestine [12]. In chicken liver, the 
enzyme is mainly present during embryonic develop- 
ment, with the highest activity on day 16 and decreasing 
rapidly thereafter until very low levels are reached at 
hatching on day 21 [ 131. In this study we tested if 
BrAcT, is a useful affinity-label for ID-III in rats and 
chickens. 
2. MATERIALS AND METHODS 
Three types of iodothyronine deiodinases have been 
identified in mammals. The type I deiodinase (ID-I) is 
capable of both inner and outer ring deiodination and 
is responsible for the greater part of peripheral T3 pro- 
duction from T4. However, the preferred substrate of 
the enzyme is rT,. The enzyme is located in the micro- 
somal fractions of liver, kidney and thyroid [ 1.21. The 
iodothyronine derivative ~-bromoacetyl-To (BrAcT,) 
has proved to be a very useful a~nity-label for ID-I, 
resulting in the identification of the = 27 kDa ID-I 
protein by SDS-PAGE [3-51. Human, rat and mouse 
ID-I have been shown to contain the rare amino acid 
selenocysteine [6-81. 
2.1. Materials 
[3,5-‘251]T3 (- 30 Ciimmol) was generously provided by Drs. C. 
Horst and R. Thoma, Henning (Berlin, Germany); [3’,.5’-‘251]rTr and 
[3’-‘251]T, (- 1700 Ci/mmol) were obtained from Amersham (Amer- 
sham, UK); thyronine (To) and iodothyronines from Henning; dithio- 
threitol (DTT), 6-n-propyl-2-thiouracil (PTU), 3,3’,5_triiodothy- 
roacetic acid (Triac) and 3,Sdiiodotyrosine (DIT) from Sigma (St. 
Louis, MO); iopanoic acid (LOP) from Sterling Winthrop (Newcastle, 
UK); electrophoresis grade SDS-PAGE reagents from Bio-Rad 
(Richmond, IL); BCA Protein Assay Reagent from Pierce Europe 
(Oud Beijerland, The Netherlands); M, markers and Sephadex LH-20 
from Pharmacia (Uppsala, Sweden); and Coomassie brilliant blue 
R-250 from Merck (Darmstadt, FRG). 
2.2. Preparation of microsomes 
The type III iodothyronine deiodinase (ID-III) is the 
least well described deiodinase. It catalyzes the inactiva- 
tion of thyroid hormone by inner ring deiodination of 
T, and T3 [1,2]. In mammals, ID-III is mainly located 
*~orres~nding author. Fax: (31) (10) 463-5430. 
Wistar rats were purchased from Harlan SpragueDawley (Zeist, 
The Netherlands). Liver and brain were isolated from IO-week-old 
male rats after decapitation. Pregnant rats and fetuses were sacrificed 
on day 20 of gestation, and the placentas, fetal livers and brains were 
isolated. Fertilized chicken eggs were obtained from a local supplier 
and incubated for 14, 16, 18 or 20 days in a forced-draught incubator 
at 37°C and 80% humidity. Eggs were opened, the embryos were 
decapitated, and the livers were isolated. All tissues were immediately 
frozen in liquid nitrogen and stored at -70°C until further use. Micro- 
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somes were prepared in bufFer A <IO mM Tris-HCI (pH 7.41, 3 mM 
EDTA rind 3 mM DTT) as previously described 1141 and stored at 
-70°C. Protein content was measured by Pierce BCA pratein assay, 
using bovine serum albumin as the standard. 
2.3. Affinity-k&ding 
BrAc[‘ZSI]T3 and non-radioactive BrAcT, were prepared essentially 
as previously published [3]. HPLC analysis demonstrated that the 
purity of BrAc[‘*‘XJT3 was 2 85%, with unreacted [‘251]T, as the main 
contaminant, while non-radioactive BrAcT, was r 95% pure. Solu- 
tions of BrAc[‘2”J]T, and BrAcT, in ethanol were pipetted into an 
Eppendorf tube, and the solvent was evaporated at 42°C under a 
stream of nitrogen. The desired amount of rnicrosomal protein in 100 
~1 buffer A was added to the residue, and the mixture was vortexed 
for 30 s, After further incubation for IO min at 37-C, labeling was 
stopped by addition of 50 ~1 of SDS-sampie buffer containing 30% 
~-mercapt~thanol and treatment for 5 min at IOV’C, Proteins were 
separated overnight by SDS-PAGE in a I4 cm 10% or 15% T, 3% C 
gel, overlaid by a 2 cm 3% T, 3% C stacking gel [ 1 S]. Gels were stained 
with Coomassie brilliant blue R-250, dried under vacuum and autora- 
diographed at -7O’C with Kodak T-mat G film. M, was determined 
by interpolation with protein markers. 
2.4. Deiodinase map 
The activity of ID-I was measured by incubation of lOL,rglmI micro- 
sorna1 protein for 20 min at 37°C with 1 PM rT, and 75 nCi 
f3’,S-“51]rT3 in 200 ~10.2 M phosphate @H 7.2),4 mM EDTA and 
5 mM DTT, followed by isolation of the inI- released on Sephadex 
IX-Z@ as previously described [16]. 
The activity of ID-III was measured by incubation of difXrent 
amounts ofmicrosomal protein For 60 min at 37°C with 1 nM ff251~T, 
in 200 ~10.2 M phosphate (pH 7.2),4 mM EDTA and 20 mM DTT. 
Both inner and outer ring labeled [l*?]T, were used, yielding identical 
results. When [3’-‘2SI]T, was used, the reactions were stopped by addi- 
tion of 300 ,~l methanol on ice, After centrifugation, the supernatants 
were analyzed for [3,3 ‘-‘251]T2 formation by HPLC on a 100 x 3.0 mm 
Chromspher CIR column (Chrompack, Middelburg, The Nether- 
lands), eluted with a 4555 (v/v) mixture of methanol and 20 mM 
ammonium acetate (PH 4.0) at a flow of 0.8 ml/rnin. When [3,5-‘251]T, 
was used, reactions were stopped by addition of 100 ~1 pooled human 
serum on ice, followed by precipitation of protein-~~d iodothyron- 
ines by addition of 500 ~1 10% trichloroacetic acid. After centrifuga- 
tion, the superuatants were analyzed for izsI- formation on Sephadex 
LH-20. Parallel incubations were done with 1 PM T,, which saturates 
the low-&, ID-III but not the high-ii, ID-I {1,2], showing negligible 
type I or non-enzymatic deiodination of T,. 
3. RESULTS 
In the rat, high ID-III activities are found in the 
microsomal fraction of placenta and brain, while the 
enzyme is mare abundant in brain of fetal than of adult 
rats. After reaction of rat placenta and brain miero- 
somes with BrAc[“‘QTs and subsequent analysis by 
SDS-PAGE, a p~o~nant radioactive band of 32 kDa 
(~32) was observed, with higher levels in fetal than in 
adult rat brain (Fig. 1). In none of these microsomes 
significant ID-I activity was found, which was associ- 
ated with the absence of a 27 kDa band (~29, represent- 
ing BrAcTJabeled ID-I, in the corresponding autora- 
diograms. 
Both fetal and adult rat liver microsomes showed 
little ID-III activity. However, reaction of fetal liver 
microsomes with BrAc[‘251]T, resulted in extensive la- 
beling of p32 (Fig. 2A). This is quite different from adult 
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Fig. 1. Labeling patterns obtained after reaction of 50 ,~g of micro- 
somal protein with 0.15 #Zi BrAc[‘2SI]T,. After SDS-PAGE film was 
exposed for 4 days. (A} Rat placenta. (B) Adult rat brain, (C> Fetal 
rat brain. 
rat liver microsomes, where labeling of ~32 is nearly 
absent (Fig. 2B). In contrast with fetal liver, micro- 
somes of adult rat liver contain high levels of ID-I activ- 
ity, leading to extensive labeling of ~27, which could 
interfere with labeling of ~32. However, inhibition of 
p27 labeling by addition of rT, and PTU resulted in 
only a minor increase in p32 labeling (Fig. 2C). Under 
these circumstances an increase was also observed in the 
labeling of a 56 kDa band, identified previausly its pro- 
tein disulfide isomerase [4], and of a 67 kDa band. These 
findings indicate that the level of p32 in adult rat liver 
microsomes is very low. 
In spite of the discrepancies found between ID-III 
activity and p32 labeling, we further investigated their 
possible relationship by analyzing the effects of sub- 
strates and inhibitors of the enzyme on BrAcT, labeling 
of ~32. Therefore, rat brain microsomes were reacted 
with BrAc[12SI]TJ in the presence of 100 PM of various 
substrate analogs and deiodinase inhibitors. Labeling of 
the microsomal proteins was not influenced by any of 
the substances tested (Fig. 3A). However, deiodination 
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Fig. 2. Labeling patterns obtained after reaction of 50 pg of micro- 
somal protein with 0.15 ,rKZi BrAr$251]T3. After SDS-PAGE film was 
exposed for 4 days. (A) Fetal rat liver. (B) Adult rat liver. (C) Adult 
rat liver in the presence of 10 fitM rT, and 100 PM PTU. 
of [12?]T, by ID-III was largely inhibited by 1 PM T,, 
T,, Triac or IOP (Fig. 3B). 
In embryonic chicken liver, highest ID-III activity 
was observed at or around day 16 of embryonic devel- 
opment (El 6); thereafter, ID-III activity decreases rap- 
idly to become nearly undetectable in adult chicken liver 
microsomes (Fig. 4A); see also [ 131). Reaction of embry- 
onic and adult chicken liver microsomes with 
B~Ac[‘~~I]T, did not reveal labeling of p32 or any other 
protein possibly correlated with ID-III activity (Fig. 
4B). In adult chicken liver microsomes ID-I has been 
identified as a 26 kDa band [16]. Figure 4 shows the 
strong correlation between affinity labeling of this 26 
kDa band and the varying ID-I activity in chicken liver 
during embryonic development. 
ID-III activity of chicken El6 liver microsomes and 
rat placenta microsomes was measured in the presence 
of increasing concentrations of BrAcT, or T3 (Fig. 5). 
In both tissues, deiodination of [1251]T3 was inhibited by 
similar concentrations of T3 and BrAcT,, with IC, val- 
ues varying between 5‘7 and 8.1 nM, After preincuba- 
tion of rat placenta or El6 chicken liver ~crosomes 
106 
with T3 or BrAcT,, time-dependent inactivation of ID- 
III was observed with BrAcT3, but not with T3, which 
persisted after removal of unreacted BrAcT, by Pen- 
efsky centrifugal column chromatography [171 (results 
not shown). These findings suggest he covalent modifi- 
cation of rat and chicken ID-III by BrAcT,. 
4. DISCUSSION 
The low apparent Km of T, (- 5 nM) for both rat and 
chicken ID-III estimated in the present study is in agree- 
ment with previously published data [19,20]. We also 
found that, although ID-III is irreversibly inactivated 
by BrAcT,, the apparent Ki of this compound is similar 
to the Km of the substrate T,. This is quite different from 
inhibition of ID-I by BrAcT3, which is half-maximum 
at = 0.1 nM of the inhibitor, a concentration much 
lower than the -K, for T3 (6 PM) or even rT, (0.06 PM) 
[3]. This is most likely caused by reaction of BrAcT, 
with the highly reactive selenocysteine residue in ID-I. 
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Fig. 3. (A) Labeling patterns obtained after reaction of 66 /fug of rat 
brain microsomal protein with 0.1 &i BrAc[“51]T, in the absence or 
presence of 100 PM of various substrate analogs and deiodinase inhib- 
itors. After SDS-PAGE film was exposed for 42 h. (B) Deiodination 
of 1 nM [‘zsIlTJT3 by 500 ,@rnl rat brain microsomal protein in the 
absence or presence of 1 PM of the compounds indicated, except hat 
PTU was added at 100 PM. Activities are expressed as a percentage 
of that in the absence of the various additions. 
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Fig. 4. (A) Ontogeny of deiodinase activities in chicken liver during the last week (E14E20) of embryonic development. ID-I was assayed using 
1 PM rT, and 10 &ml microsomal protein. ID-III was assayed using 1 nM T, and lOO.~uglml icrosomal protein. (B) Autoradiogram of labeling 
patterns obtained after reaction of 100 @g embryonic chicken liver mi~osomal protejn with 0.25 PCi BrAc[‘251jT~. After SDS-PAGE film was 
exposed for 25 h. 
The difference in sensitivity to inactivation by BrAcT, 
between ID-I and ID-III may be explained by the find- 
ing that ID-III is apparently not a selenoenzyme [21]. 
Santini et al. have recently reported similar findings 
concerning the inhibition of ID-III activity as well as the 
labeling of a 31 kDa protein with BrAcT, in rat placen- 
tal microsomes 1181. They suggested that this 31 kDa 
protein is the substrate-binding subunit of ID-III, al- 
though its labeling was only partially inhibited in the 
presence of as high as 1.50 ,uM T,, while it was also 
observed in tissues with no ID-III activity. However, we 
have serious doubts about the relationship between p32 
and ID-III. Firstly, BrAcT, labeling of p32 is observed 
not only in tissues with high ID-III activity (rat brain 
and placenta) but also in tissues with little or no enzyme 
activity (fetal rat liver and adult rat spleen) [22]. Sec- 
ondly, BrAcT, labeling of p32 is not observed in embry- 
onic chicken liver, which shows very similar levels and 
properties of ID-III activity as rat placenta, and which 
is as sensitive to BrAcT, inhibition as rat ID-III. 
Thirdly, BrAcT, labeling of p32 is not inhibited in the 
presence of 100 ,uM T3, which is > 104-fold higher than 
its apparent & and, thus, should completely block 
modification of the substrate-binding site by BrAcT,, 
which has a similar affinity for the enzyme as T,. There- 
fore, our findings do not support the hypothesis that 
p32 is a subunit of ID-III. 
Although ID-III is irreversibly inactivated by 
BrAcT,, we were not able to identify the enzyme by 
affinity-labeling with this compound, which could be 
explained if: (1) BrAc[‘251]T, is degraded after coupling 
to ID-III, leading to loss of radioactivity; (2) the 
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Fig. 5. divination of 1 nM [‘zsIjT3 by chicken El6 liver micro~mes (A; 20 #g protein/ml) or rat placenta microsomes (B; 25 #g protei~ml} in 
the presence of increasing concentrations of BrAcT,. Results are expressed as a percentage of that without additions. 
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amount of ID-III present in the various microsomes is 
too low to allow sufficient incorporation of 
BrAc[1251]T,; or (3) the M, of ID-III is close to that of 
another prominently labeled protein, interfering with 
the detection of labeled ID-III. 
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